A20 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF3882
Target Cell Organism: Mouse
Target Cell Alternative Name: A-20
Target Cell Name: A20
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide A20-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
A20
Target Cell Organism
Mouse
Target Cell Background
A20 [A-20] is a BALB/c B cell lymphoma line derived from a spontaneous reticulum cell neoplasm found in an old BALB/cAnN mouse. This cell line can be used in immunology research.
Target Cell Alternative Name
A-20
Related Diseases
Lymphoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry